Approximation of Corrected Calcium Concentrations in Advanced Chronic Kidney Disease Patients with or without

Yoshio Kaku1, Susumu Ookawara1, Haruhisa Miyazawa1

  • 1Division of Nephrology, First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan.

Nephron Extra
|November 12, 2015
PubMed

Insights

A new formula accurately estimates corrected calcium in advanced chronic kidney disease (CKD) patients, outperforming traditional methods. This improves serum calcium assessment for CKD G4-G5 and CKD G5D populations.

Area of Science:

  • Nephrology
  • Clinical Chemistry

Background:

  • The conventional Payne formula for serum calcium correction is inadequate for advanced chronic kidney disease (CKD) patients.
  • Accurate serum calcium estimation is crucial for managing CKD patients.

Purpose of the Study:

  • To develop and validate a new formula for corrected serum calcium estimation in advanced CKD patients (G4-G5 and G5D).
  • To improve the accuracy of calcium measurements in patients with impaired kidney function.

Main Methods:

  • Collected 1,922 samples from CKD G4+G5 patients and 341 from CKD G5D patients.
  • Measured total calcium (TCa), ionized calcium (iCa2+), and clinical parameters.
  • Used stepwise multiple linear regression to derive a new formula, comparing it to measured corrected TCa.

Main Results:

  • Devised new formulas for approximated corrected TCa for CKD G4+G5 and CKD G5D patients incorporating albumin, pH, phosphorus, and bicarbonate.
  • Receiver operating characteristic analysis demonstrated high accuracy for the new formula in detecting specific corrected TCa ranges.
  • Intraclass correlation coefficients showed superior agreement with the new formula compared to existing methods.

Conclusions:

  • The newly developed approximated corrected TCa formula demonstrates superior agreement with measured corrected TCa in advanced CKD patients.
  • This new formula offers a more reliable method for assessing calcium levels in CKD G4+G5 and CKD G5D populations.
Abstract

Related Concept Videos

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
312
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
621
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
307
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
607
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance...
343
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
580